Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

ClinicalTrials.gov ID: NCT03090100

Public ClinicalTrials.gov record NCT03090100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of guselkumab compared with secukinumab for the treatment of participants with moderate to severe plaque-type psoriasis.

Study identification

NCT ID
NCT03090100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,048 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2017 (Actual)
Primary completion
Aug 2, 2018 (Actual)
Completion
Sep 20, 2018 (Actual)
Last update posted
Oct 1, 2019

2017 – 2018

United States locations

U.S. sites
44
U.S. states
23
U.S. cities
41
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35233 —
Southern California Permanente Medical Group Los Angeles California 90027 —
Dermatology Specialists Oceanside California 92056 —
MedDerm Associates San Diego California 92103 —
San Luis Dermatology & Laser Clinic, Inc San Luis Obispo California 93405 —
Southern California Dermatology Santa Ana California 92701 —
Clinical Research Center of Connecticut Danbury Connecticut 06810 —
Olympian Clinical Research Clearwater Florida 33757 —
Florida Academic Dermatology Centers Coral Gables Florida 33134 —
Renstar Medical Research Ocala Florida 34470 —
Park Avenue Dermatology Orange Park Florida 32073 —
Atlanta Dermatology, Vein & Research Center Alpharetta Georgia 30022 —
Advanced Medical Research Atlanta Georgia 30328 —
Marietta Dermatology Clinical Research Marietta Georgia 30060 —
Arlington Dermatology Rolling Meadows Illinois 60008 —
Northshore Universite Healthsystem Skokie Illinois 60077 —
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256 —
Indiana Clinical Trial Center Plainfield Indiana 46168 —
Dermatology Specialists Louisville Kentucky 40241 —
DermAssociates, PC Rockville Maryland 20850 —
Great Lakes Research Group Bay City Michigan 48706 —
Henry Ford Medical Center Detroit Michigan 49202 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Somerset Skin Centre Troy Michigan 48084 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Central Dermatology St Louis Missouri 63117 —
Windsor Dermatology East Windsor New Jersey 08520-2505 —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
Dermatology Consulting Services, PLLC High Point North Carolina 27262 —
Dermatologists of Greater Columbus Bexley Ohio 43209 —
The Ohio State University Gahanna Ohio 43230 —
Central Sooner Research Norman Oklahoma 73071 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Oregon Medical Research Center Portland Oregon 97223 —
University of Pittsburgh Department of Dermatology Pittsburgh Pennsylvania 15213 —
Clinical Partners Johnston Rhode Island 02919 —
Austin Dermatology Associates Austin Texas 78705 —
Modern Research Associates Dallas Texas 75231 —
Menter Dermatology Research Institute Dallas Texas 75246-1615 —
Suzanne Bruce and Associates - The Center for Skin Research Houston Texas 77056-4132 —
Progressive Clinical Research San Antonio Texas 78213 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Virginia Clinical Research Norfolk Virginia 23322 —
Dermatology Associates of Seattle Seattle Washington 98101-1498 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03090100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03090100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →